We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alzheimer’s Association Upset About Big Price Tag for New Alzheimer’s Drug
Alzheimer’s Association Upset About Big Price Tag for New Alzheimer’s Drug
The Alzheimer’s Association, the largest nonprofit funder for Alzheimer’s research, has blasted Biogen for its plans to price Aduhelm (aducanumab) — the first drug approved to treat Alzheimer’s in 18 years — at $56,000 a year.